Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

Published:2016-01-08 Issue:3 Volume:196 Page:1400-1411
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Björklund Andreas T.^ORCID,Clancy Trevor^ORCID,Goodridge Jodie P.,Béziat Vivien,Schaffer Marie,Hovig Eivind,Ljunggren Hans-Gustaf,Ljungman Per T.,Malmberg Karl-Johan

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference62 articles.

1. Innate or Adaptive Immunity? The Example of Natural Killer Cells

2. Functionally and Structurally Distinct NK Cell Receptor Repertoires in the Peripheral Blood of Two Human Donors

3. Human NK Cell Education by Inhibitory Receptors for MHC Class I

4. Licensing of natural killer cells by host major histocompatibility complex class I molecules

5. Immune memory redefined: characterizing the longevity of natural killer cells

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is HLA-E with its receptors an immune checkpoint or an antigenic determinant in allo-HCT?;Best Practice & Research Clinical Haematology;2024-06

2. Phase I non-randomized clinical trial of allogeneic natural killer cells infusion in acute myeloid leukemia patients;BMC Cancer;2023-11-10

3. NKG2A discriminates natural killer cells with a suppressed phenotype in pediatric acute leukemia;Journal of Leukocyte Biology;2023-09-21

4. Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapse;Frontiers in Immunology;2023-02-07

5. Relapse Protection Following Early Cytomegalovirus Reactivation after Hematopoietic Stem Cell Transplantation Is Limited to HLA-C Killer Cell Immunoglobulin-Like Receptor Ligand Homozygous Recipients;Transplantation and Cellular Therapy;2021-08